Zydus Lifesciences Limited has unveiled Aerolife Mini™, a next-generation pMDI enhancer, aiming to revolutionise inhaler use for asthma and COPD patients. This innovative device, launched under an exclusive licensing agreement with AeroDel Technology Innovations Pvt. Ltd., marks India’s first foldable and portable spacer, offering significant convenience for users.
India faces a mounting challenge with chronic respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD), exacerbated by factors such as air pollution and smoking. Millions rely on inhaled therapies to manage symptoms and improve their quality of life. However, effective drug delivery to the lungs remains a critical issue, with studies showing that 94% of patients make at least one critical error in inhaler use, leading to reduced therapeutic benefits.
Spacer devices are known to enhance the delivery of drugs from pressurised metered-dose inhalers (pMDIs) by reducing coordination errors. Despite their clinical efficacy, existing spacer devices are often bulky and inconvenient for daily use, leading to poor adherence. Aerolife Mini™ addresses these issues with its compact, foldable design, promising better drug deposition, improved compliance, and greater patient confidence.
This launch is part of Zydus’ strategy to build a sustainable, innovation-led respiratory franchise focused on patient-centric solutions. The company aims to transform respiratory care through innovative drug-device combinations.
Zydus Lifesciences Ltd. is a global lifesciences company dedicated to empowering people to live healthier lives through innovative healthcare solutions. With a workforce of over 29,000, including 1,500 scientists, Zydus is committed to discovering and developing therapies that address unmet healthcare needs.
AeroDel Technology Innovations Pvt. Ltd. focuses on developing affordable, patient-centric respiratory devices to improve access to care in India and globally. Supported by various government and entrepreneurial initiatives, AeroDel aims to enhance healthcare delivery through innovative technologies.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).